NCT00434213View on ClinicalTrials.gov

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

PHASE4CompletedINTERVENTIONAL

Enrollment

309

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

July 31, 2008

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Daytrana

Methylphenidate Transdermal System (MTS)

Trial Locations (29)

79423

Lubbock

Unknown

Scottsdale

Irvine

San Marcos

Spring Valley

Wildomar

Boulder

Gainesville

Miami

Winter Park

Libertyville

Northbrook

Overland Park

Bardstown

Owensboro

Cambridge

Kalamazoo

Las Vegas

Toms River

Rochester

Cleveland

Columbus

Portland

Salem

Philadelphia

Jackson

Austin

San Antonio

Norfolk

Sponsors

Lead Sponsor

Noven Therapeutics

All Listed Sponsors

lead

Noven Therapeutics

INDUSTRY